.png)
.png)
Adjuvant chemoradiation with weekly cisplatin did not significantly improve survival outcomes — but did increase toxicities — compared with adjuvant radiotherapy alone in women with early-stage cervical carcinoma who have intermediate risk factors following radical hysterectomy, a phase 3 trial found. The current standard for women with early-stage disease and intermediate-risk factors is radiotherapy alone...
Copyright © 2024 buzzstream. All Rights Reserved
Copyright © 2024 BuzzStream. All Rights Reserved.
All content on this website, including but not limited to text, images, graphics, logos, articles, and other materials, is the property of BuzzStream and is protected by international copyright laws. No part of this content may be reproduced, distributed, transmitted, displayed, published, or broadcast without BuzzStream's prior written permission. Unauthorized use of the content is strictly prohibited and may result in legal action.
For inquiries regarding the use or licensing of content, please contact us at 1-832-482-2215.
Feel free to customize it further if needed!
